World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
50
Citations
8937
World Ranking
4455
National Ranking
102

Overview

Roger D. Kouyos is affiliated with the University of Zurich in Switzerland. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a focus on Infectious Diseases, Virology, Epidemiology, Emergency Medicine, and Immunology.

The main topics covered in their work include:

  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • SARS-CoV-2 and COVID-19 Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Roger D. Kouyos has contributed to a variety of frequent publication venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • BMC Infectious Diseases

Recent papers authored or co-authored by Roger D. Kouyos include:

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis, 2023, The Lancet HIV
  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Efficient microbial colony growth dynamics quantification with ColTapp, an automated image analysis application, 2020, Scientific Reports
  • A Treatment-as-Prevention Trial to Eliminate Hepatitis C Among Men Who Have Sex With Men Living With Human Immunodeficiency Virus (HIV) in the Swiss HIV Cohort Study, 2020, Clinical Infectious Diseases

The scientist collaborates frequently with several co-authors, including:

  • Huldrych F. Günthard
  • Enos Bernasconi
  • Matthias Cavassini
  • Dominique L. Braun
  • Alexandra Calmy

Best Publications

  • Population biological principles of drug-resistance evolution in infectious diseases

    Pia Abel zur Wiesch;Roger Kouyos;Jan Engelstädter;Roland R Regoes

  • Estimating the Basic Reproductive Number from Viral Sequence Data

    Tanja Stadler;Roger Kouyos;Viktor von Wyl;Sabine Yerly

  • Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland

    Roger D. Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • Determinants of HIV-1 broadly neutralizing antibody induction

    Peter Rusert;Roger D Kouyos;Claus Kadelka;Hanna Ebner

  • Epistasis between deleterious mutations and the evolution of recombination.

    Roger D. Kouyos;Olin K. Silander;Sebastian Bonhoeffer

  • Contribution of a mutational bias in hepatitis C virus replication to the genetic barrier in the development of drug resistance

    Megan H. Powdrill;Egor P. Tchesnokov;Robert A. Kozak;Rodney S. Russell

  • Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

    Nadine Bachmann;Chantal von Siebenthal;Valentina Vongrad;Teja Turk

  • The state of affairs in the kingdom of the Red Queen

    Marcel Salathé;Roger D. Kouyos;Sebastian Bonhoeffer

  • Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

    Roger D Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load

    Samuel Alizon;Viktor von Wyl;Tanja Stadler;Roger D. Kouyos

  • Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics.

    Wen Hsuan W. Lin;Roger D. Kouyos;Robert J. Adams;Bryan T. Grenfell;Bryan T. Grenfell

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS).

    Alexandra U Scherrer;Anna Traytel;Dominique L Braun;Alexandra Calmy

  • Exploring the complexity of the HIV-1 fitness landscape.

    Roger D. Kouyos;Gabriel E. Leventhal;Trevor Hinkley;Mojgan Haddad

  • Frequency and Spectrum of Unexpected Clinical Manifestations of Primary HIV-1 Infection

    Dominique L. Braun;Roger D. Kouyos;Belinda Balmer;Christina Grube

  • Inferring epidemic contact structure from phylogenetic trees.

    Gabriel E. Leventhal;Roger D. Kouyos;Tanja Stadler;Viktor von Wyl

  • Stochastic or deterministic: what is the effective population size of HIV-1?

    Roger D. Kouyos;Christian L. Althaus;Sebastian Bonhoeffer

  • HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis.

    Unknown

  • Hospital-community interactions foster coexistence between methicillin-resistant strains of Staphylococcus aureus.

    Roger Kouyos;Eili Klein;Eili Klein;Eili Klein;Bryan T. Grenfell

  • The path of least resistance: aggressive or moderate treatment?

    Roger D. Kouyos;Roger D. Kouyos;C. Jessica E. Metcalf;C. Jessica E. Metcalf;Ruthie Birger;Eili Y. Klein;Eili Y. Klein

  • Cycling empirical antibiotic therapy in hospitals: meta-analysis and models.

    Pia Abel zur Wiesch;Roger Kouyos;Sören Abel;Wolfgang Viechtbauer

  • Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

    Luisa Salazar‐Vizcaya;Roger D. Kouyos;Cindy Zahnd;Gilles Wandeler

Frequent Co-Authors

Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Jürg Böni
Jürg Böni University of Zurich
Matthias Cavassini
Matthias Cavassini University of Lausanne
Sabine Yerly
Sabine Yerly University of Geneva
Manuel Battegay
Manuel Battegay University Hospital of Basel
Thomas Klimkait
Thomas Klimkait University of Basel
Andri Rauch
Andri Rauch University of Bern
Alexandra Calmy
Alexandra Calmy University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology in the USA opens doors to diverse career opportunities, many of which can be pursued through flexible online programs. For those with unique circumstances, there are online colleges that accept felons, making education more accessible to a broader group of learners.

One emerging pathway is toward healthcare roles such as a functional medicine nurse practitioner. This career combines microbiological knowledge with patient care in holistic treatment approaches, showcasing the interdisciplinary possibilities of a microbiology background.

For those interested in the administrative or billing side of healthcare, becoming a CPC (Certified Professional Coder) offers a specialized avenue to apply scientific knowledge in managing health information efficiently.

Similarly, the role of a health information manager salary reflects growing demand for professionals skilled in overseeing medical data and records—a critical function that benefits from a solid foundation in microbiological sciences.

Best Scientists Citing Roger D. Kouyos

Trending Scientists

Recently Published Articles